TY - JOUR
T1 - A Longitudinal Description of the Health-Related Quality of Life Among Individuals at High Risk After SARS-CoV-2 Infection
T2 - A Dutch Multicenter Observational Cohort
AU - Vergouwe, Magda
AU - Birnie, Emma
AU - van Veelen, Sarah
AU - Biemond, Jason J.
AU - Appelman, Brent
AU - Peters-Sengers, Hessel
AU - de Bree, Godelieve J.
AU - behalf of the TURN-COVID Study Group
AU - Popping, Stephanie
AU - Joost Wiersinga, W.
AU - van Ittersum, F.J.
N1 - Publisher Copyright:
© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
PY - 2025/2/1
Y1 - 2025/2/1
N2 - Background. Health-related quality of life (HRQoL) data post–COVID-19 in patients with medical conditions associated with severe disease are lacking. Here, we assess the longitudinal impact of COVID-19 on HRQoL and employment status in individuals at high risk. Methods. This multicenter prospective cohort study included individuals at high risk for severe disease who were hospitalized or not-hospitalized with SARS-CoV-2 infection (September 2021–February 2024). Questionnaires about HRQoL and employment status were collected at 3, 6, and 12 months post–COVID-19 and retrospectively recalled and reported for pre–COVID-19. With a mixed effects model, we assessed the course of and risk factors for changes in HRQoL utility score. Results. Among 332 individuals (median age, 59.8 years [IQR, 48.8–67.1]; 50.6% female), 184 (55.4%) were hospitalized for COVID-19 (intensive care unit admission, 12.0%). High-risk factors included solid organ transplantation (19.6%), hematologic malignancies (28.0%), and immunosuppressive medication use (56.6%). The median HRQoL utility score declined from 0.85 (IQR, 0.74–1.00) pre–COVID-19 to 0.81 (0.70–0.92) 12 months post–COVID-19 (P = .007). Solid organ transplant recipients and patients requiring oxygen therapy were at risk for an HRQoL decrease over 1 year. At 12 months, 45.3% of all employed responders had reported sick leave related to COVID-19 symptoms. Employed patients who reported sick leave had lower median HRQoL utility scores (0.81 [IQR, 0.72–0.91]) than those who did not (0.89 [0.86–1.00], P = .002). Conclusions. Solid organ transplant recipients and individuals requiring oxygen therapy experience a substantial HRQoL decline over 12 months post–COVID-19. Moreover, almost half of employed participants reported COVID-19–related sick leave, correlating with lower HRQoL. This highlights the continuous burden of COVID-19 for this vulnerable population and supports the implementation of preventive approaches.
AB - Background. Health-related quality of life (HRQoL) data post–COVID-19 in patients with medical conditions associated with severe disease are lacking. Here, we assess the longitudinal impact of COVID-19 on HRQoL and employment status in individuals at high risk. Methods. This multicenter prospective cohort study included individuals at high risk for severe disease who were hospitalized or not-hospitalized with SARS-CoV-2 infection (September 2021–February 2024). Questionnaires about HRQoL and employment status were collected at 3, 6, and 12 months post–COVID-19 and retrospectively recalled and reported for pre–COVID-19. With a mixed effects model, we assessed the course of and risk factors for changes in HRQoL utility score. Results. Among 332 individuals (median age, 59.8 years [IQR, 48.8–67.1]; 50.6% female), 184 (55.4%) were hospitalized for COVID-19 (intensive care unit admission, 12.0%). High-risk factors included solid organ transplantation (19.6%), hematologic malignancies (28.0%), and immunosuppressive medication use (56.6%). The median HRQoL utility score declined from 0.85 (IQR, 0.74–1.00) pre–COVID-19 to 0.81 (0.70–0.92) 12 months post–COVID-19 (P = .007). Solid organ transplant recipients and patients requiring oxygen therapy were at risk for an HRQoL decrease over 1 year. At 12 months, 45.3% of all employed responders had reported sick leave related to COVID-19 symptoms. Employed patients who reported sick leave had lower median HRQoL utility scores (0.81 [IQR, 0.72–0.91]) than those who did not (0.89 [0.86–1.00], P = .002). Conclusions. Solid organ transplant recipients and individuals requiring oxygen therapy experience a substantial HRQoL decline over 12 months post–COVID-19. Moreover, almost half of employed participants reported COVID-19–related sick leave, correlating with lower HRQoL. This highlights the continuous burden of COVID-19 for this vulnerable population and supports the implementation of preventive approaches.
KW - COVID-19
KW - HRQoL utility score
KW - SARS-CoV-2
KW - health-related quality of life
KW - immunocompromised
UR - https://www.scopus.com/pages/publications/85218626965
U2 - 10.1093/ofid/ofaf055
DO - 10.1093/ofid/ofaf055
M3 - Article
C2 - 39974282
SN - 2328-8957
VL - 12
JO - Open Forum Infect. Dis.
JF - Open Forum Infect. Dis.
IS - 2
ER -